The Endocrine Society has issued an update to the organization’s 2019 clinical practice guideline on pharmacologic management of osteoporosis to include romosozumab.
In patients with axial spondyloarthritis, use of lateral DXA, as opposed to the conventional anteroposterior projection, significantly increased the prevalence of low BMD measurements.
A second course of romosozumab led to either gains in or maintenance of bone mineral density in postmenopausal women who were 12 months off treatment or transitioning from denosumab.
The Company is currently conducting a comparative study with the aim of having the treatment designated as a therapeutic equivalent to Forteo.
The American Society for Bone and Mineral Research developed 13 clinical recommendations (7 primary and 6 secondary) to address the undertreatment of osteoporosis-related fractures and prevent secondary fracture among persons aged ≥65 years with hip or vertebral fractures.
Researchers determined whether gut microbiota was associated with bone mineral density in individuals at high risk for reduced BMD and fractures.
Older pubertal age was associated with lower BMD in adolescence and early adulthood, despite some catch-up during puberty.
Bariatric surgery can impact rheumatic diseases, apart from it being an effective weight loss option for people with obesity and severe associated comorbidities.
Based on emerging evidence and expert opinion, a task force put together by the International Society for Clinical Densitometry created position statements on the assessment of BMD in transgender and gender-nonconforming individuals.
More than a quarter of postmenopausal women and men ≥50 years of age were found to have osteoporosis a decade after undergoing Roux-en-Y gastric bypass surgery.
